Related Experiment Videos
[Rheumatoid factor in systemic lupus erythematosus]
Summary
Rheumatoid factors (RF) were detected in 12% of systemic lupus erythematosus (SLE) patients, particularly those with chronic polyarthritis. RF presence did not correlate with disease duration, age, or impact renal lesions in SLE patients.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Context:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
- Rheumatoid factors (RF) are autoantibodies commonly associated with rheumatoid arthritis.
- The presence and significance of RF in SLE patients require further elucidation.
Purpose:
- To investigate the prevalence and clinical significance of rheumatoid factors (RF) in patients with systemic lupus erythematosus (SLE).
- To determine the association between RF and clinical manifestations, disease duration, and age in SLE patients.
- To evaluate the effect of RF on complement fixation to antinuclear factors and the occurrence of renal lesions.
Summary:
- Rheumatoid factors (RF) were identified in 12 out of 105 (11.4%) systemic lupus erythematosus (SLE) patients.
- RF positivity was significantly higher in SLE patients with coexisting chronic polyarthritis.
- No correlation was found between RF and patient age or disease duration. Cold precipitation patterns of RF did not differ between SLE and progressive polyarthritis.
- RF did not impede in vitro complement fixation to antinuclear factors.
- Renal lesions and uremia occurred with similar frequency in SLE patients with and without RF.
Impact:
- This study highlights the association of rheumatoid factors with chronic polyarthritis in SLE patients.
- The findings suggest that RF may serve as a potential biomarker for specific clinical phenotypes within SLE.
- Understanding the role of RF in SLE can aid in refining diagnostic and prognostic approaches.